病灶内注射干扰素α-2b治疗Buschke-Loewenstein肿瘤。
Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour.
作者信息
Tsambaos D, Monastirli A, Kapranos N, Georgiou S, Pasmatzi E, Berger H
机构信息
Department of Dermatology, University of Patras, Greece.
出版信息
Acta Derm Venereol. 1994 Nov;74(6):457-9. doi: 10.2340/0001555574457459.
PMID:7701880
Abstract
A patient with a Buschke-Loewenstein tumour associated with human papillomavirus type 6/11 is reported. He was intralesionally treated with human recombinant alpha-2b interferon (9 x 10(6) IU/day) three times weekly. The tumour completely disappeared within 5 months of continuous treatment which was well tolerated. Sixteen months after completion of therapy the patient remains well and free of disease.
摘要
报告了一名患有与6/11型人乳头瘤病毒相关的Buschke-Loewenstein肿瘤的患者。他每周三次接受人重组α-2b干扰素（9×10⁶国际单位/天）瘤内注射治疗。连续治疗5个月内肿瘤完全消失，且耐受性良好。治疗结束16个月后，患者情况良好，无疾病复发。
Zotero 插件